Ceftazidime-avibactam (Avycaz), meropenem-vaborbactam (Vabomere), and ceftolozane-tazobactam (Zerbaxa) are three new beta-lactam/beta-lactamase inhibitor combination antibiotics that have gained FDA approval in recent years. In this article a comparison of Avycaz, Vabomere, and Zerbaxa is provided. Authored By: Timothy P. Gauthier, Pharm.D., BCPS-AQ … [Read more...]
Myths & Facts Of Being A PGY1 Pharmacy Resident
Pharmacy students hear many rumors regarding what happens to new pharmacists who opt to become a PGY1 pharmacy resident. What is myth and what is fact? Here a recent PGY1 graduate takes a stab at clearing the air by identifying what she found to be myth and what she found to be fact. Authored By: Melissa Santibañez, Pharm.D. I have always … [Read more...]